Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

When evaluating a subject’s brain structure volumes, looking at absolute volumes is the first step. However, naturally occurring variances due to age or gender might distort the impression these values provide. Differences in overall head size might distort the impression further, and result in questions such as: Is this hippocampus exceptionally small or is my patient’s overall brain size small and the smaller hippocampus is expected for somebody their age?

Normalizing the brain structure to the intracranial volume (ICV) adjusts for differences in overall head size; further restrictions of comparison to male and female subjects of a defined age provides even better results.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Using a normative data set established out of large population data gives context to the personalized brain structure volumes over a very broad age range. The WHO and CDC have been using normative reference charts for growth evaluations in children for many years. The same approach is used in the visualization of NeuroQuant®, results displaying an individual’s brain structure volume measurements relative to a healthy population. This allows NeuroQuant to deliver a precise impression of where that individual’s brain structure volume lies within an age- and gender- based reference chart, which aids physicians in their assessment of neurodegenerative conditions.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Displaying the normalized patient brain structure volumes with reference to healthy cohorts based on age and gender is an integral part of NeuroQuant and a feature of each NeuroQuant report. Since launch in 2007, the NeuroQuant normative database has been continuously tested and validated against tens of thousands of clinical cases.

Want to learn more about Cortechs.ai Normative Database? Cortechs.ai has developed a Normative Database white paper, which is now available for download.

More Resources

03/20/2026

Quantitative MRI, the McDonald Criteria, and the Future of Multiple Sclerosis Care

MRI is the foundation for diagnosing and monitoring multiple sclerosis (MS)

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

Scroll to Top